Impact of virus subtype and host IFNL4 genotype on large-scale RNA structure formation in the genome of hepatitis C virus by Simmonds, P, Kuypers, L, Irving, WL, McLauchlan, J, Cooke, GS, Barnes, E, Ansari, MA

Blood donation screening for hepatitis B virus core antibodies: The importance of confirmatory testing and initial implication for rare blood donor groups by Fu, MX, Ingram, J, Roberts, C, Nurmi, V, Watkins, E, Dempsey, N, Golubchik, T, Breuer, J, Brailsford, S, Irving, WL, Andersson, M, Simmonds, P, Harvala, H

Reconstruction of the historic time course of blood‐borne virus contamination of clotting factor concentrates, 1974–1992 by McClure, CP, Kean, K, Reid, K, Mayne, R, Fu, MX, Rajendra, P, Gates, S, Breuer, J, Harvala, H, Golubchik, T, Tarr, AW, Irving, WL, Makris, M, Simmonds, P

Viral genome wide association study identifies novel hepatitis C virus polymorphisms associated with sofosbuvir treatment failure by Smith, DA, Fernandez-Antunez, C, Magri, A, Bowden, R, Chaturvedi, N, Fellay, J, McLauchlan, J, Foster, GR, Irving, WL, Barnes, E, Simmonds, P, Pedergnana, V, Ramirez, S, Bukh, J, Ansari, MA

Real world SOF/VEL/VOX retreatment outcomes and viral resistance analysis for HCV patients with prior failure to DAA therapy by Smith, DA, Bradshaw, D, Mbisa, J, Manso, CF, Bibby, D, Singer, J, Thomson, E, Filipe, A, Aranday-Cortes, E, Ansari, MA, Brown, A, Hudson, E, Benselin, J, Healy, B, Troke, P, McLauchlan, J, Barnes, E, Irving, WL

aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis by Fan, R, Papatheodoridis, G, Sun, J, Innes, H, Toyoda, H, Xie, Q, Mo, S, Sypsa, V, Guha, IN, Kumada, T, Niu, J, Dalekos, G, Yasuda, S, Barnes, E, Lian, J, Suri, V, Idilman, R, Barclay, ST, Dou, X, Berg, T, Hayes, PC, Flaherty, JF, Zhou, Y, Zhang, Z, Buti, M, Hutchinson, SJ, Guo, Y, Calleja, JL, Lin, L, Zhao, L, Chen, Y, Janssen, HLA, Zhu, C, Shi, L, Tang, X, Gaggar, A, Wei, L, Jia, J, Irving, WL, Johnson, PJ, Lampertico, P, Hou, J